1125 related articles for article (PubMed ID: 27581457)
21. Spontaneous Synaptic Activation of Muscarinic Receptors by Striatal Cholinergic Neuron Firing.
Mamaligas AA; Ford CP
Neuron; 2016 Aug; 91(3):574-86. PubMed ID: 27373830
[TBL] [Abstract][Full Text] [Related]
22. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.
Zhang W; Yamada M; Gomeza J; Basile AS; Wess J
J Neurosci; 2002 Aug; 22(15):6347-52. PubMed ID: 12151512
[TBL] [Abstract][Full Text] [Related]
23. Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease.
Xiang Z; Thompson AD; Jones CK; Lindsley CW; Conn PJ
J Pharmacol Exp Ther; 2012 Mar; 340(3):595-603. PubMed ID: 22135383
[TBL] [Abstract][Full Text] [Related]
24. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M
Joseph L; Thomsen M
Behav Brain Res; 2017 Jun; 329():75-83. PubMed ID: 28442355
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory.
Wang Q; Wei X; Gao H; Li J; Liao J; Liu X; Qin B; Yu Y; Deng C; Tang B; Huang XF
Neuroscience; 2014 May; 267():57-66. PubMed ID: 24613723
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of basal and amphetamine-stimulated extracellular signal-regulated kinase (ERK) phosphorylation in the rat forebrain by muscarinic acetylcholine M4 receptors.
He N; Mao LM; Sturich AW; Jin DZ; Wang JQ
Brain Res; 2018 Jun; 1688():103-112. PubMed ID: 29577888
[TBL] [Abstract][Full Text] [Related]
27. Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline.
Dencker D; Wörtwein G; Weikop P; Jeon J; Thomsen M; Sager TN; Mørk A; Woldbye DP; Wess J; Fink-Jensen A
J Neurosci; 2011 Apr; 31(16):5905-8. PubMed ID: 21508215
[TBL] [Abstract][Full Text] [Related]
28. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease.
Ztaou S; Amalric M
Neurochem Int; 2019 Jun; 126():1-10. PubMed ID: 30825602
[TBL] [Abstract][Full Text] [Related]
29. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
Frau L; Morelli M; Simola N
Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
[TBL] [Abstract][Full Text] [Related]
30. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y.
Robertson GS; Staines WA
Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982
[TBL] [Abstract][Full Text] [Related]
31. Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia.
Lim SAO; Xia R; Ding Y; Won L; Ray WJ; Hitchcock SA; McGehee DS; Kang UJ
Neurobiol Dis; 2015 Apr; 76():67-76. PubMed ID: 25661301
[TBL] [Abstract][Full Text] [Related]
32. Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson's Disease Models.
Tanimura A; Du Y; Kondapalli J; Wokosin DL; Surmeier DJ
Neuron; 2019 Feb; 101(3):444-458.e6. PubMed ID: 30658860
[TBL] [Abstract][Full Text] [Related]
33. Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice.
Zhang K; Chammas C; Soghomonian JJ
Neuroscience; 2015 Sep; 303():586-94. PubMed ID: 26188284
[TBL] [Abstract][Full Text] [Related]
34. Striatal cholinergic interneurons generate beta and gamma oscillations in the corticostriatal circuit and produce motor deficits.
Kondabolu K; Roberts EA; Bucklin M; McCarthy MM; Kopell N; Han X
Proc Natl Acad Sci U S A; 2016 May; 113(22):E3159-68. PubMed ID: 27185924
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Phosphorylation of AMPA Glutamate Receptors by Muscarinic M4 Receptors in the Striatum In vivo.
Mao LM; He N; Jin DZ; Wang JQ
Neuroscience; 2018 Apr; 375():84-93. PubMed ID: 29432883
[TBL] [Abstract][Full Text] [Related]
36. The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats.
Ma Y; Zhan M; OuYang L; Li Y; Chen S; Wu J; Chen J; Luo C; Lei W
Behav Brain Res; 2014 Jun; 266():37-45. PubMed ID: 24613235
[TBL] [Abstract][Full Text] [Related]
37. Increased GABAergic transmission in neuropeptide Y-expressing neurons in the dopamine-depleted murine striatum.
Rubi L; Fritschy JM
J Neurophysiol; 2020 Apr; 123(4):1496-1503. PubMed ID: 32159408
[TBL] [Abstract][Full Text] [Related]
38. M1 and M4 receptors modulate hippocampal pyramidal neurons.
Dasari S; Gulledge AT
J Neurophysiol; 2011 Feb; 105(2):779-92. PubMed ID: 21160001
[TBL] [Abstract][Full Text] [Related]
39. Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.
F Hernández L; Castela I; Ruiz-DeDiego I; Obeso JA; Moratalla R
Mov Disord; 2017 Apr; 32(4):530-537. PubMed ID: 28256089
[TBL] [Abstract][Full Text] [Related]
40. Striatal cholinergic interneurons and Parkinson's disease.
Tanimura A; Pancani T; Lim SAO; Tubert C; Melendez AE; Shen W; Surmeier DJ
Eur J Neurosci; 2018 May; 47(10):1148-1158. PubMed ID: 28677242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
